Successful algorithm for selective liver biopsy in the right hepatic lobe live donor (RHLD).
Routine versus selective predonation liver biopsy (LBx) remains controversial for assuring the safety of right hepatic lobe live donor (RHLD). Between December 1999 and March 2007, 403 potential RHLD were evaluated; 142 donated. Indications for selective LBx were: abnormal liver function tests or imaging studies, body mass index (BMI) >28, history of substance abuse or family history of immune mediated liver disease. All donors had a LBx at the time of surgery. Of 403 potential RLD, 149(36.9%) were accepted as donors, 25(6.3%) had their recipient receive a deceased donor graft, 94(23.4%) were rejected, 52(12.9%) stopped the evaluation process, 76(18.8%) withdrew from the process and 7(1.7%) are currently completing evaluation. Eighty-seven (21.5%) met criteria and were biopsied. Seventy-three (83.9%) had either normal (n = 24) or macrosteatosis <10% (n = 49); 51 of these donated. Abnormal LBx eliminated 15 potential donors. No significant abnormalities were found in donation biopsies of donors not meeting algorithm criteria. Three of 87 (3.4%) had complications requiring overnight admission (2 for pain, 1 for bleeding; transfusion not required). Use of this algorithm resulted in 78% of potential donors avoiding biopsy and potential complications. No significant liver pathology was identified in donors not meeting criteria for evaluation LBx. Routine predonation LBx is unnecessary in potential RHLD.
Simpson
M A
MA
Department of Hepatobiliary Surgery and Liver Transplantation, Lahey Clinic, Burlington, MA, USA. mary.a.simpson@lahey.org
Verbesey
J E
JE
Khettry
U
U
Morin
D S
DS
Gordon
F D
FD
Burns
D L
DL
Robson
K
K
Pomposelli
J J
JJ
Jenkins
R L
RL
Pomfret
E A
EA
D000328:Adult; D000465:Algorithms; D001706:Biopsy / Q000009:adverse effects; D005234:Fatty Liver / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D008099:Liver / Q000033:anatomy & histology / Q000166:cytology* / Q000473:pathology; D016031:Liver Transplantation / Q000473:pathology*; D019520:Living Donors; D018579:Patient Selection; D011183:Postoperative Complications / Q000473:pathology; D015203:Reproducibility of Results; D012449:Safety; D016896:Treatment Outcome